Odenton, MD, United States of America

Kenneth Richard Boheler

This inventor holds 2 USPTO granted patents. Top assignee: The University of Hong Kong. Active years: 2023-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kenneth Richard Boheler. Retrieved from https://idiyas.com/inventor/kenneth-richard-boheler

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 50.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2023-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Kenneth Richard Boheler

Introduction

Kenneth Richard Boheler is an accomplished inventor based in Odenton, MD (US). He has made significant contributions to the field of biomedical research, particularly in the area of stem cell technology. With a total of 2 patents, his work has the potential to impact various medical applications.

Latest Patents

One of his latest patents is titled "Mesenchymal stromal cells as a reprogramming source for iPSC induction." This patent provides a method for generating induced mesenchymal stromal cells (iMSCs) and outlines their use in reprogramming. Another notable patent is "Identification of subpopulations of cardiomyocytes," which discloses methods for isolating and utilizing subpopulations of cardiomyocytes derived from mammalian stem or progenitor cells. These innovations are particularly relevant for cardiac disease modeling, drug screening, and cardiac regeneration.

Career Highlights

Kenneth Richard Boheler is affiliated with The University of Hong Kong, where he continues to advance his research in stem cell applications. His work is recognized for its potential to contribute to breakthroughs in regenerative medicine and therapeutic strategies.

Collaborations

He has collaborated with notable colleagues, including Ngar-Yun Ellen Poon and Chi-Fung Chan, enhancing the scope and impact of his research endeavors.

Conclusion

Kenneth Richard Boheler's innovative work in stem cell technology and cardiomyocyte research exemplifies the potential of scientific advancements in medicine. His contributions are paving the way for future developments in regenerative therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…